• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2022.17109

Sarcopenia: features of pathogenesis, diagnosis, treatment and rehabilitation in COVID-19 patients

[Reviews]
Lyudmila Vladimirovna Zaklyakova; Konstantin Konstantinovich Zaklyakov; Boleslav Levitan; Aleksey Osadchuk; Bella Shamgunova; Maxim A. Voznyuk;

A global problem in all countries is the aging of the population due to the lengthening of the life span. The number of age related diseases, including sarcopenia, rises with increasing age. People of the elderly and senile age were especially vulnerable in terms of the number of infections, the severity of the course of the disease, the number of deaths, for 2 years of the COVID-19 pandemic. The pandemic requires restrictive measures on the movement of citizens up to the introduction of a lockdown. This entails a decrease in physical activity and a rapid progression of sarcopenia, which worsens the prognosis of COVID-19 in this category of citizens, not only in the acute stage of the disease, but also in the following months due to an exacerbation of cardiovascular diseases, kidney diseases.

Download

References:
1. WHO Director-General’s opening remarks at the media briefing for Geneva-based journalists 11.03.2020. Available at: www.who.int/ru/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-oncovid-19---11-march-2020. Accessed March 11, 2020.
2. Lim W. S., Liang C. K., Assantachai P., Auyeung T. W., Kang L. [et al.]. COVID-19 and older people in Asia: Asian Working Group for Sarcopenia calls to actions. Geriatr. Gerontol. Int. 2020;20(6):547-558. https://doiorg/10.1111/ggi.13939
3. Anker S. D., Morley J. E., von Haehling S. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle. 2016;7:512-514. https://doi.org/10.1002/jcsm.12147
4. Cruz-Jentoft A. J., Bahat G., Bauer J., BoirieY., Bruyère O. [et al.]. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16-31. https://doi.org/10.1093/ageing/afy169
5. Murkamilov I. T., Ajtbaev K. A., Kudajbergenova I. O., Fomin V. V., Murkamilova Zh. A., Yusupov F. A. Damage of the muscle system in Covid-19. Arhiv vnutrennej mediciny. – The Russian Archives of Internal Medicine. 2021;11(2):146-153. (In Russ.). https://doi.org/10.20514/2226-6704-2021-11-2-146-153
6. Sabirov I. S., Abduvahapov B. Z., Mamedova M. S., Sabirova A. I. Gerotological aspects of the clinical and pathogenetic features of the new coronavirus infection COVID-19. Nauchnoe nasledie. – Scientific heritage. 2021;61:46-53. (In Russ.).
7. Antony P., Vijayan R. Molecular dynamics simulation study of the interaction between human angiotensin converting enzyme 2 and spike protein receptor binding domain of the SARS-CoV-2 B.1.617 variant. Biomolecules. 2021;11:1244-1254. https://doi.org/10.3390/biom11081244
8. Ou J., Zhou Z., Dai R., Zhang J., Zhao S. [et al.]. V367F mutation in SARS-CoV-2 Spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity. J. Virol. 2021;95(16): e00617-21. https://doi.org/10.1128/JVI.00617-21
9. Trouwborst I., Verreijen A., Memelink R., Massanet P., Boirie Y. [et al.]. Exercise and nutrition strategies to counteract sarcopenic obesity. Nutrients. 2018;10(5):605. https://doi.org/10.3390/nu10050605
10. Simpson R. J., Kunz H., Agha N., Graff R. Exercise and the regulation of immune functions. Prog. Mol. Biol. Transl. Sci. 2015;135:355-380. 11. Nielsen T. L., Vissing J., Krag T. O. Antimyostatin treatment in health and disease: the story of great expectations and limited success. Cells. 2021;10:533. https://doi.org/10.3390/cells1003053
12. Shcherbakov V. I., Skosyreva G. A., Ryabichenko T. I. Role of myokines in regulation of apowerex change. Byulleten’ sibirskoj mediciny. – Bulletin of Siberian Medicine. 2012;3:173-178. (In Russ.).
13. Kukes V. G., Gazdanova A. A., Furalyov V. A., Marinin V. F., Perkov A. V. [et al.]. Modern conception of myostatin biological role and clinical significance as the main regulator of muscle growth and differentiation. Meditsinskii vestnik Severnogo Kavkaza. – Medical News of North Caucasus. 2021;16(3):327-332. (In Russ.). https://doi.org/10.14300/mnnc.2021.16079
14. Iizuka K., Machida T., Hirafuji M. Skeletal muscle is an endocrine organ. J. Pharmacol. Sci. 2014;125:125-131. https://doi.org/10.1254/jphs.14R02CP 15. Gomarasca M., Banfi G., Lombardi G. Myokines: the endocrine coupling of skeletal muscle and bone. Adv. Clin. Chem. 2020;94:155-218. https://doi.org/10.1016/bs.acc.2019.07.010
16. Nishikawa H., Fukunishi S., Asai A., Yokohama K., Nishiguchi S., Higuchi K. Pathophysiology and mechanisms of primary sarcopenia (Review). Int. J. Mol. Med. 2021;48(2):156. https://doi.org/10.3892/ijmm.2021.4989
17. Vasyukova O. V., Kas’yanova Yu. V., Okorokov P. L., Bezlepkina O. B. Myokines and adipomyokines: inflammatory mediators or unique molecules of targeted therapy for obesity? Problemy Endokrinolo- gii. – Endocrinology Problems. 2021;(67)4:36-45. (In Russ.). https://doi.org/10.14341/probl12779
18. Masenko V. L., Kokov A. N., Grigor’eva I. I., Krivoshapova K. E. Radiology methods of the sarcopenia diagnosis. Issledovaniya i praktika v medicine. – Research and practice in medicine. 2019;(6)4:127-137. (In Russ.).
19. Zakrevskij A. I., Fyodorova A. A., Pasechnik I. N., Kutepov D. E. Sarcopenia: how to diagnose it? Klinicheskoe pitanie i metabolism. – Clinical nutrition and metabolism. 2021;2(1):13-22. (In Russ.). https://doi.org/10.17816/clinutr71107
20. Abe T., Loenneke J. P., Young K. C., Thiebaud R. S. Validity of ultrasound prediction equations for total and regional muscularity in middle-aged and older men and women. Ultrasound Med. Biol. 2015;41:557-564. https://doi.org/10.1016/j.ultrasmedbio.2014.09.007
21. Midorikawa T., Ohta M., Hikihara Y., Torii S., Sakamoto S. Prediction and validation of total and regional skeletal muscle volume using B-mode ultrasonography in Japanese prepubertal children. Br. J. Nutr. 2015;114(8):1209-1217. https://doi.org/i10.1017/S0007114515002585
22. Watanabe Y., Yamada Y., Fukumoto Y., Ishihara T., Yokoyama K. [et al.]. Echo intensity obtained from ultrasonography images reflecting muscle strength in elderly men. Clin. Interv. Aging. 2013;8:993-998. https://doi.org/10.2147/CIA.S47263
23. Ticinesi A., Meschi T., Narici M. V., Lauretani F., Maggio M. [et al.]. Muscle ultrasound and sarcopenia in older individuals: a clinical perspective. J. Am. Med. Dir. Assoc. 2017;18(4):290-300. https://doi.org/10.1016/j.jamda.2016.11.013
24. Perkisas S., Baudry S., Bauer J., Beckwée D., De Cock A. M. [et al.]. Application of ultrasound for muscle assessment in sarcopenia: towards standardized measurements. Eur. Geriatr. Med. 2018;9(6):739-757. https://doi.org/10.1007/s41999-018-0104-9
25. Leigheb M., de Sire A., Colangelo M., Zagaria D., Grassi F. A. [et al.]. Sarcopenia diagnosis: reliability of the ultrasound assessment of the tibialis anterior muscle as an alternative evaluation tool. Diagnostics (Basel). 2021;11:2158. https://doi.org/10.3390/diagnostics11112158
26. Nijholt W., Scafoglieri A., Jager-Wittenaar H., Hobbelen J. S. M., Schans C. P. [et al.]. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J. Cachexia Sarcopenia Muscle. 2017;8:702- 712. https://doi.org/10.1002/jcsm.12210
27. Zhou Z., Yu T., Du R., Fan G., Liu Y. [et al.]. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
28. Lakhin R. E., Zhirnova E. A., Shchegolev A. V., Iovanikich O., Zhelezniak I. S. [et al.]. Lung ultrasoundin COVID-19 pneumonia: comparison with computed tomography. An observation prospective clinical trial. Vestnik intensivnoj terapii A. I. Saltanova. – Annals of Critical Care. 2021;2:82-93. (In Russ.). https://doi.org/10.23934/2223-9022-2019-8-4-418-422
29. Petrikov S. S., Popova I. A., Abuchina V. M., Muslimov R. Sh., Khamidova L. T. [et al.]. Diagnostic value of lung ultrasound versus chest CT in COVID-19. Sechenovskij vestnik. – Sechenov Medical Journal. 2020;11(2):5-19. (In Russ.). https://doi.org/10.47093/2218-7332.2020.11.2.5-18
30. Fedele D., de Francesco A., Riso S., Collo A. Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: an overview. Nutrition. 2021;81:111016-111034. https://doi.org/10.1016/j.nut.2020.111016
31. Kobelyackij Yu. Yu. Review of the international guidelines for nutritional support in patients with COVID-19 in the intensive care unit. Medicina nevіdkladnih stanіv. – Emergency Medicine. 2020;16(2):21-30. (In Russ.). https://doi.org/10.22141/2224-0586.16.2.2020.203137
32. Murthy S., Gomersall C. D., Fowler R. A. Care for critically ill patients with COVID-19. JAMA. 2020;323(15):1499- 1500. https://doi.org/10.1001/jama.2020.3633
33. World Health Organization. Clinical management of COVID-19: living guidance. Available at: https://doi.org/apps.who.int/iris/bitstream/handle/10665/338871/WHO2019-nCoV-clinical-web_annex-2021. Accessed January 25, 2021.
34. Grechko A. V., Evdokimov E. A., Kotenko O. N., Krylov K., Kryukov E. [et al.] Nutritional support for patients with COVID-19 coronavirus infection. Кlinithescoe pitanie i metabolism. – Clinical nutrition and metabolism. 2020;1(2):56-91. (In Russ.). https://doi.org/10.36425/clinnutrit42278
35. González-Salazar L. E., Guevara-Cruz M., Hernández-Gómez K. G., Zúñiga A. E. S. Nutritional management of the critically ill inpatient with COVID-19. Nutr. Hosp. 2020;34(3):622-630. https://doi.org/10.20960/nh.03180
36. Siuka D., Pfeifer M., Pinter B. Vitamin D supplementation during the COVID-19 pandemic. Mayo Clin. Proc. 2020;95(8):1804-1805. https://doi.org/10.1016/j.mayocp.2020.05.036
37. Brenner H. Vitamin D supplementation to prevent COVID-19 infections and deaths-accumulating evidence from epidemiological and intervention studies calls for immediate action. Nutrients. 2021;13(2):411. https://doi.org/10.3390/nu13020411
38. Micielska K., Flis M., Kortas J. A., Rodziewicz-Flis E., Antosiewicz J. [et al.]. Nordic walking rather than high intensity interval training reduced myostatin concentration more effectively in elderly subjects and the range of this drop was modified by metabolites of vitamin D. Nutrients. 2021;13(12):4393. https://doi.org/10.3390/nu13124393
39. Hawryłkowicz V., Lietz-Kijak D., Kaźmierczak-Siedlecka K., Sołek-Pastuszka J., Stachowska L. [et al.]. Patient nutrition and probiotic therapy in COVID-19: what do we know in 2021? Nutrients. 2021;13(10):3385-3403. https://doi.org/10.3390/nu13103385
40. Crispo A., Bimonte S., Porciello G., Forte C. A. Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors. Infect. Agent. Cancer. 2021;16(1):62-82. https://doi.org/10.1186/s13027-021-00401-3
41. Horoshilov I. E. Sarcopenia: diagnostic methods and treatment prospects. Lechashchij vrach. – Attending physician. 2017;8:36-41. (In Russ.).
42. Ali A. M., Kunugi H. Approaches to nutritional screening in patients with Coronavirus disease 2019 (COVID-19). Int. J. Environ. Res. Public Health. 2021;18(5):2772. https://doi.org/10.3390/ijerph18052772
43. Umbrello M., Guglielmetti L., Formenti P., Antonucci E., Cereghini S. [et al.]. Qualitative and quantitative muscle ultrasound changes in patients with COVID-19-relatedARDS. Nutrition. 2021;91-92:111449. https://doi.org/10.1016/j.nut.2021.111449
44. Puthucheary Z. A., Rawal J., Mc Phail M., Connolly B., Ratnayake G. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591-600. https://doi.org/10.1001/jama.2013.278481
45. Chan J., Lu Y.-C., Yao M., Kosik R. O. Correlation between hand grip strength and regional muscle mass in older Asian adults: an observational study. BMC Geriatr. 2022;22(1):206. https://doi.org/10.1186/s12877-022-02898-8
46. Willemke N., Aldo S., Harriët J. W., Hobbelen J. S. M., Schans C. P. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J. Cachexia Sarcopenia Muscle. 2017;(8):702-712. https://doi.org/10.1002/jcsm.12210
47. Temporary guidelines Ministry of Health of the Russian Federation.Medical rehabilitation at a new coronavirus infection (COVID-19) (version 2). 30.07.2020. [In Russ..
48. The prevention, diagnosis and treatment of the new coronavirus infection (COVID-19). Temporary guidelines Ministry of Health of the Russian Federation (version 13.1). 17.11.2021. [In Russ..
49. Postigo-Martin P., Cantarero-Villanueva I., Lista-Paz A., Castro-Martín E., Arroyo-Morales M., Seco-Calvo J. COVID-19 rehabilitation prospective surveillance model for use by physiotherapists. J. Clin. Med. 2021;10(8):1691. https://doi.org/10.3390/jcm10081691
50. COVID-19 rapid guideline: managing the long-term effects of COVID-19. National Institute for Health and Care Excellence: Clinical Guidelines. London. NICE. 2020. https://doi.org/10.1093/gerona/61.1.72.10.1136/bmj.n136
51. Furtado G. E., Letieri R.V., Caldo-Silva A., Sardão V. A., Teixeira A. M. Sustaining efficient immune functions with regular physical exercise in the COVID-19 era and beyond. Eur. J. Clin. Invest. 2021;51(5):13485-13495. https://doi.org/10.1093/gerona/61.1.72.10.1111/eci.13485
52. Damiot A., Pinto A. J., Turner J. E., Gualano B. Immunological implications of physical inactivity among older adults during the COVID-19. Gerontology. 2020;66(5):431- 438. https://doi.org/10.1159/000509216
53. Filgueira T. O., Castoldi A., Santos L. E. R., de Amorim G. J., de Sousa M. S. [et al.]. The relevance of a physical active lifestyle and physical fitness on immune defense: mitigating disease burden, with focus on COVID-19. Consequences Souto Front. Immunol. 2021;12:587146. https://doi.org/10.3389/fimmu.2021.587146
54. Ranasinghe C., Ozemek C., Arena R. Exercise and well – being during COVID 19 – time to boost your immunity. Expert. Rev. Anti. Infect. Ther. 2020;18(12):1195-1200. https://doi.org/10.1080/14787210.2020.1794818

Keywords: sarcopenia, COVID-19, pathophysiology, diagnosis, treatment, rehabilitation